WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1997019699) DRUG COMPOSITION
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1997/019699    International Application No.:    PCT/JP1996/003450
Publication Date: 05.06.1997 International Filing Date: 26.11.1996
Chapter 2 Demand Filed:    19.12.1996    
IPC:
A61K 9/00 (2006.01), A61K 9/20 (2006.01), A61K 33/08 (2006.01), A61K 45/06 (2006.01)
Applicants: YAMANOUCHI PHARMACEUTICAL CO., LTD. [JP/JP]; 3-11, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103 (JP) (For All Designated States Except US).
HASHIMOTO, Yoshimi [JP/JP]; (JP) (For US Only).
SHIOZAWA, Hiroyoshi [JP/JP]; (JP) (For US Only).
KISHIMOTO, Hideyuki [JP/JP]; (JP) (For US Only).
SETOGUCHI, Yoichi [JP/JP]; (JP) (For US Only)
Inventors: HASHIMOTO, Yoshimi; (JP).
SHIOZAWA, Hiroyoshi; (JP).
KISHIMOTO, Hideyuki; (JP).
SETOGUCHI, Yoichi; (JP)
Agent: NAGAI, Shozo; Yamanouchi Pharmaceutical Co., Ltd., Patent & Information Dept., 17-1, Hasune 3-chome, Itabashi-ku, Tokyo 174-8612 (JP)
Priority Data:
7/307512 27.11.1995 JP
Title (EN) DRUG COMPOSITION
(FR) COMPOSITION DE MEDICAMENT
Abstract: front page image
(EN)An oral solid drug composition for the therapy of digestive disorders for which diminution of gastric hydrochloric acid is effective, which improves the condition of the patient immediately after administration and retains it effect over long. It is characterized by comprising a histamine H¿2? receptor antagonist, a lowly neutralizing gastric antacid drug, and a highly neutralizing gastric antacid drug coated with a polymer base which is insoluble in water independently of pH.
(FR)Cette composition de médicament solide à administrer par voie buccale, qui sert au traitement des troubles digestifs contre lesquels une diminution de l'acide chlorhydrique gastrique est efficace, améliore l'état du patient immédiatement après son administration et agit de façon prolongée. Cette composition se caractérise en ce qu'elle comprend un antagoniste de récepteur d'histamine H¿2?, un médicament antiacide gastrique faiblement neutralisant, ainsi qu'un médicament antiacide gastrique hautement neutralisant enduit d'une base polymère qui est insoluble dans l'eau indépendamment du pH.
Designated States: AL, AM, AU, AZ, BA, BB, BG, BR, BY, CA, CN, CU, CZ, EE, GE, HU, IL, IS, JP, KE, KG, KR, KZ, LC, LK, LR, LS, LT, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, RO, RU, SD, SG, SI, SK, TJ, TM, TR, TT, UA, UG, US, UZ, VN.
African Regional Intellectual Property Organization (KE, LS, MW, SD, SZ, UG)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)